WEBINAR: Design, develop, and characterize novel gene therapies on a unified digital platform REGISTER
CASE STUDY

Jounce Therapeutics: Migrating to an all-in-one informatics solution for immunotherapy R&D

Jounce logo

Enabling the immune system to find and attack tumors

A pioneer of precision immunotherapies for cancer, Jounce Therapeutics uses a number of different analytics techniques to identify biomarkers in the tumor microenvironment (TME) that can help them match their drug candidates with the right patients.

Company

Number of employees: 51 – 250

Industry: Biotechnology

Location: Cambridge, MA, USA

Goal

Support R&D with a single platform that tracks all characterization data for a given sample from concept to clinic.

CHALLENGES

Valuable time wasted on busywork and maintaining software integrations 
Web lab and informatics groups lost time transferring files and copying/pasting data across their multiple software platforms. The informatics group also spent valuable time maintaining and connecting their multiple software ‘solutions’.

Difficulty finding data across multiple systems
Critical data was stored in multiple software applications across different servers, complicating report generation, insight generation, and regulatory compliance.

Too many software logins and trainings
The friction of multiple logins and the need for specific training on how to best use each different software platform frustrated scientists and impacted productivity.

Results
  • 1000s
    of unique biologics and 100,000s of containers were imported from legacy systems into Benchling, centralizing all data on a single platform
  • 100%
    adoption rate among licensed users at Jounce
  • 4.8/5
    scientist satisfaction rating with Benchling